Literature DB >> 9587956

Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions.

T Kosa1, T Maruyama, N Sakai, N Yonemura, S Yahara, M Otagiri.   

Abstract

PURPOSE: The aim of this study was to investigate the characteristics of the structural transitions and changes in ligand binding properties of different albumins during the pH-dependent structural transition, often referred to as the N-B transition.
METHODS: Structural transitions were evaluated by means of spectrometry, differential scanning calorimetry and chemical modification. In addition, ligand binding properties were investigated using typical site-specific bound drugs (warfarin, phenylbutazone, ibuprofen and diazepam).
RESULTS: Conformational changes, including N-B transition, clearly occurred in albumins from all species used in this study. The conformational stabilities of all the albumins were clearly lost in the weakly alkaline pH range. This was probably the result of the destruction of salt bridges between domain I and domain III in the albumin molecule. In addition, the profiles of the ANS-induced fluorescence were different and could be classified into two patterns, suggesting that hydrophobic pockets in the albumin molecules were different for the different species. The data suggest that the amino acid residues responsible for the transitions were some of the His residues located in domain I. Further, the ligand binding properties of the albumins were slightly different but statistically significant.
CONCLUSIONS: The overall mechanisms of the N-B transition may be similar for all the albumins, but its impact is considerably different among the species in terms of both structural characteristics and ligand binding properties. Furthermore, the transitions appear to be multi-step transitions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587956     DOI: 10.1023/a:1011986028529

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotatory dispersion studies.

Authors:  W J LEONARD; K K VIJAI; J F FOSTER
Journal:  J Biol Chem       Date:  1963-06       Impact factor: 5.157

2.  The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin.

Authors:  O J Bos; J F Labro; M J Fischer; J Wilting; L H Janssen
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

3.  Mechanism by which warfarin binds to human serum albumin. Stopped-flow kinetic experiments with two large fragments of albumin.

Authors:  O J Bos; M J Fischer; J Wilting; L H Janssen
Journal:  Biochem Pharmacol       Date:  1989-06-15       Impact factor: 5.858

4.  A proton nuclear magnetic resonance study of human serum albumin in the neutral pH region.

Authors:  J F Labro; L H Janssen
Journal:  Biochim Biophys Acta       Date:  1986-09-26

5.  Evidence for distinct consecutive steps in the neutral to base transition of human serum albumin.

Authors:  B J t' Hart; J Wilting; J J de Gier
Journal:  Biochem Pharmacol       Date:  1986-03-15       Impact factor: 5.858

6.  Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.

Authors:  R Weisiger; J Gollan; R Ockner
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

7.  The pH dependence of the thermodynamics of the interaction of diazepam with human serum albumin.

Authors:  L H Janssen; J H Dröge; F C Durlinger; F J Fruytier
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

8.  The role of albumin conformation in the binding of diazepam to human serum albumin.

Authors:  J Wilting; B J Hart; J J De Gier
Journal:  Biochim Biophys Acta       Date:  1980-12-16

9.  A comparative study of some physico-chemical properties of human serum albumin samples from different sources--II. The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam.

Authors:  J H Dröge; J Wilting; L H Janssen
Journal:  Biochem Pharmacol       Date:  1982-12-01       Impact factor: 5.858

10.  Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface.

Authors:  E L Forker; B A Luxon
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more
  6 in total

1.  Protein-bound calcium phosphate in uremic rat serum: a quantitative study.

Authors:  Hong-Xing Fan; Bao-Di Gou; Yu-Xi Gao; Gang Wu; Shu-Hu Liu; Fan Li; Tian-Lan Zhang
Journal:  J Biol Inorg Chem       Date:  2020-08-24       Impact factor: 3.358

2.  On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human.

Authors:  Sami S Zoghbi; Kacey B Anderson; Kimberly J Jenko; David A Luckenbaugh; Robert B Innis; Victor W Pike
Journal:  J Pharm Sci       Date:  2011-12-13       Impact factor: 3.534

3.  Reversible two-step unfolding of heme-human serum albumin: a (1)H-NMR relaxometric and circular dichroism study.

Authors:  Gabriella Fanali; Giampiero De Sanctis; Magda Gioia; Massimo Coletta; Paolo Ascenzi; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2008-10-21       Impact factor: 3.358

4.  Spectroscopic Studies on the Molecular Ageing of Serum Albumin.

Authors:  Mariola Chudzik; Małgorzata Maciążek-Jurczyk; Bartosz Pawełczak; Anna Sułkowska
Journal:  Molecules       Date:  2016-12-27       Impact factor: 4.411

5.  Human Serum Albumin Aggregation/Fibrillation and its Abilities to Drugs Binding.

Authors:  Małgorzata Maciążek-Jurczyk; Kamil Janas; Jadwiga Pożycka; Agnieszka Szkudlarek; Wojciech Rogóż; Aleksandra Owczarzy; Karolina Kulig
Journal:  Molecules       Date:  2020-01-31       Impact factor: 4.411

6.  The Influence of Oxidative Stress on Serum Albumin Structure as a Carrier of Selected Diazaphenothiazine with Potential Anticancer Activity.

Authors:  Małgorzata Maciążek-Jurczyk; Beata Morak-Młodawska; Małgorzata Jeleń; Wiktoria Kopeć; Agnieszka Szkudlarek; Aleksandra Owczarzy; Karolina Kulig; Wojciech Rogóż; Jadwiga Pożycka
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.